These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 21360595)
41. The neurochemical and stimulatory effects of putative metabolites of 3,4-methylenedioxyamphetamine and 3,4-methylenedioxymethamphetamine in rats. Yeh SY; Hsu FL Pharmacol Biochem Behav; 1991 Jul; 39(3):787-90. PubMed ID: 1723801 [TBL] [Abstract][Full Text] [Related]
42. Disposition of methylenedioxymethamphetamine and three metabolites in the brains of different rat strains and their possible roles in acute serotonin depletion. Chu T; Kumagai Y; DiStefano EW; Cho AK Biochem Pharmacol; 1996 Mar; 51(6):789-96. PubMed ID: 8602874 [TBL] [Abstract][Full Text] [Related]
43. Evidence that both intragastric and subcutaneous administration of methylenedioxymethylamphetamine (MDMA) produce serotonin neurotoxicity in rhesus monkeys. Kleven MS; Woolverton WL; Seiden LS Brain Res; 1989 May; 488(1-2):121-5. PubMed ID: 2472850 [TBL] [Abstract][Full Text] [Related]
44. Reduced (+/-)-3,4-methylenedioxymethamphetamine ("Ecstasy") metabolism with cytochrome P450 2D6 inhibitors and pharmacogenetic variants in vitro. Ramamoorthy Y; Yu AM; Suh N; Haining RL; Tyndale RF; Sellers EM Biochem Pharmacol; 2002 Jun; 63(12):2111-9. PubMed ID: 12110370 [TBL] [Abstract][Full Text] [Related]
46. Validated liquid chromatographic-electrospray ionization mass spectrometric assay for simultaneous determination of 3,4-methylenedioxymethamphetamine and its metabolites 3,4-methylenedioxyamphetamine, 3,4-dihydroxymethamphetamine, and 4-hydroxy-3-methoxymethamphetamine in squirrel monkey plasma. Mueller M; Peters FT; Ricaurte GA; Maurer HH J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Aug; 855(2):262-70. PubMed ID: 17646137 [TBL] [Abstract][Full Text] [Related]
47. Hydrolysis of 3,4-methylenedioxymethamphetamine (MDMA) metabolite conjugates in human, squirrel monkey, and rat plasma. Mueller M; Kolbrich-Spargo EA; Peters FT; Huestis MA; Ricaurte GA; Maurer HH Anal Bioanal Chem; 2009 Mar; 393(6-7):1607-17. PubMed ID: 19183967 [TBL] [Abstract][Full Text] [Related]
49. Reduction of [3H]6-nitroquipazine-labelled 5-hydroxytryptamine uptake sites in rat brain by 3,4-methylenedioxymethamphetamine. Hashimoto K; Goromaru T Fundam Clin Pharmacol; 1990; 4(6):635-41. PubMed ID: 1710592 [TBL] [Abstract][Full Text] [Related]
50. Serotonin neurotoxicity after (+/-)3,4-methylenedioxymethamphetamine (MDMA; "Ecstasy"): a controlled study in humans. McCann UD; Ridenour A; Shaham Y; Ricaurte GA Neuropsychopharmacology; 1994 Apr; 10(2):129-38. PubMed ID: 7517677 [TBL] [Abstract][Full Text] [Related]
51. Methamphetamine neurotoxicity and striatal glutamate release: comparison to 3,4-methylenedioxymethamphetamine. Nash JF; Yamamoto BK Brain Res; 1992 May; 581(2):237-43. PubMed ID: 1356579 [TBL] [Abstract][Full Text] [Related]
52. Methylenedioxymethamphetamine-induced hyperthermia and neurotoxicity are independently mediated by 5-HT2 receptors. Schmidt CJ; Black CK; Abbate GM; Taylor VL Brain Res; 1990 Oct; 529(1-2):85-90. PubMed ID: 1980848 [TBL] [Abstract][Full Text] [Related]
53. The role of metabolism in 3,4-(+)-methylenedioxyamphetamine and 3,4-(+)-methylenedioxymethamphetamine (ecstasy) toxicity. Monks TJ; Jones DC; Bai F; Lau SS Ther Drug Monit; 2004 Apr; 26(2):132-6. PubMed ID: 15228153 [TBL] [Abstract][Full Text] [Related]
54. Determination of MDMA and its three metabolites in the rat perfused liver. Jamali B; Ardakani YH; Foroumadi A; Kobarfard F; Rouini MR J Anal Toxicol; 2013; 37(6):357-61. PubMed ID: 23729636 [TBL] [Abstract][Full Text] [Related]
55. Serotonergic neurotoxicity of MDMA (ecstasy) in the developing rat brain. Meyer JS; Ali SF Ann N Y Acad Sci; 2002 Jun; 965():373-80. PubMed ID: 12105113 [TBL] [Abstract][Full Text] [Related]
56. Bacterial plate assays and electrochemical methods: an efficient tandem for evaluating the ability of catechol-thioether metabolites of MDMA ("ecstasy") to induce toxic effects through redox-cycling. Felim A; Urios A; Neudörffer A; Herrera G; Blanco M; Largeron M Chem Res Toxicol; 2007 Apr; 20(4):685-93. PubMed ID: 17355154 [TBL] [Abstract][Full Text] [Related]
57. Chloral hydrate anesthesia antagonizes the neurotoxicity of 3,4-methylenedioxymethamphetamine. Schmidt CJ; Black CK; Abbate GM; Taylor VL Eur J Pharmacol; 1990 Nov; 191(2):213-6. PubMed ID: 1982264 [TBL] [Abstract][Full Text] [Related]
58. Serotonin neurotoxicity in rats after combined treatment with a dopaminergic agent followed by a nonneurotoxic 3,4-methylenedioxymethamphetamine (MDMA) analogue. Johnson MP; Huang XM; Nichols DE Pharmacol Biochem Behav; 1991 Dec; 40(4):915-22. PubMed ID: 1726189 [TBL] [Abstract][Full Text] [Related]
59. Selective 5-hydroxytryptamine2 receptor antagonists protect against the neurotoxicity of methylenedioxymethamphetamine in rats. Schmidt CJ; Abbate GM; Black CK; Taylor VL J Pharmacol Exp Ther; 1990 Nov; 255(2):478-83. PubMed ID: 1978728 [TBL] [Abstract][Full Text] [Related]
60. Neurotoxicity of the psychedelic amphetamine, methylenedioxymethamphetamine. Schmidt CJ J Pharmacol Exp Ther; 1987 Jan; 240(1):1-7. PubMed ID: 2433425 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]